Lidocaine (Versatis, Remicard, Remicaine, Remicaine Topical, Remicaine Jelly, Xylotox S.E. Plain, Xylotox Plain S.E., Lignotox, Remicane, Locaine)
Lidocaine
Adcock ingram limited
Registration
- Applicant
- Adcock ingram limited
- Certificate holder
- Adcock Ingram Ltd
- Registrations
- 13
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Versatis 5 % EACH PLASTER CONTAINS LIDOCAINE 700,0 mg | 700 mgMedicated plaster. | 43038243/3.2.3/0382Approved 2 December 2020 | Registered | Not determined | PIPIL |
| Remicard EACH 1 ml SOLUTION CONTAINS LIDOCAINE HYDROCHLORIDE 100 mg | Not listed | E0035E/6.2/35 | Cancelled | Not determined | None |
| Remicaine ointment 100 G LIDOCAINE A 5,0 G | Ointment | G1347 | Old Medicine | Not determined | None |
| Remicaine 4 % topical solution / spray 100 ML LIDOCAINE HYDROCHLORIDE A 4,0 G | 4 % /Solution spray | G1348 | Old Medicine | Not determined | None |
| Remicaine jelly EACH 100 g GEL CONTAINS LIDOCAINE HYDROCHLORIDE A 2,0 g | 100 gTopical jelly | G1349Approved 2 December 2020 | Old Medicine | Not determined | PIPIL |
| Xylotox S.E. Plain EACH 2,0 ml SOLUTION CONTAINS :LIDOCAINE HYDROCHLORIDE A 40,0 mg | Not listed | G2799 | Old Medicine | Not determined | None |
| Xylotox 2 % plain S.E. EACH 1 ML CONTAINS :LIDOCAINE HYDROCHLORIDE A = ANHYDROUS 20 mg | 2 % | G2803 | Old Medicine | Not determined | None |
| Lignotox EACh 1 ml SOLUTION CONTAINS LIDOCAINE HYDROCHLORIDE A 20 mg | Not listed | G2824 | Old Medicine | Not determined | None |
| Remicaine 0,5 % EACH 20 ML VIAL CONTAINS LIDOCAINE HYDROCHLORIDE A 100 MG | 0,5 % | G2827 | Old Medicine | Not determined | None |
| Remicane 1 % vial EACH ml SOLUTION CONTAINS LIDOCAINE HYDROCHLORIDE A 10,0 mg | 1 %Vial | G2828 | Old Medicine | Not determined | None |
| Remicaine 2 % vial EACH ML CONTAINS LIDOCAINE HYDROCHLORIDE A 20 MG | 2 %Vial | G2829 | Old Medicine | Not determined | None |
| Remicaine 2 % ampoule EACH 1,0 ml OF SOLUTION CONTIANS LIDOCAINE HYDROCHLORIDE A 20,0 mg | 2 %Ampoule | G2830 | Old Medicine | Not determined | None |
| Locaine EACH 1 ml SOLUTION CONTAINS LIDOCAINE HYDROCHLORIDE HEMIHYDRATE EQUIVALENT TO 2O mg LIDOCAINE HYDROCHLORIDE | Not listed | V0007V/4/7 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Lidocaine
- when intended for ophthalmic or parenteral use;
- when intended for the treatment of neuropathic pain associated with previous herpes zoster infection;
- except when intended for topical use; (S1)
- except in oral preparations containing 2 percent or less of lidocaine per dosage form. (S1)
Consolidated Schedules 06 July 2026, lines 6923 to 6935
S1: Lidocaine
- when intended for topical use;
- in oral preparations containing 2 percent or less of lidocaine, per dosage unit;
- except when intended for ophthalmic or parenteral use; (S4)
- except when intended for the treatment of neuropathic pain associated with previous herpes zoster infection. (S4)
Consolidated Schedules 06 July 2026, lines 777 to 786
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
Drag to rotate. Structure from PubChem CID 3676.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.